Amgen Inc.

NAS: AMGN
Pharmaceuticals
Thousand Oaks CA
Title 1Chairman; President
Executive 1Mr. Robert A. Bradway, Chairman; President | Chairman; President
2015 Revenue (US$ Millions)$21,662
2014 Revenue (US$ Millions)$20,063
Revenue Growth (%)7.97%
Net Income (US$ Millions)$6,939
Common Shares Outstanding (Millions)$754
Earnings Per Share (US$)$9.06
Price To Earnings Ratio19.3
Total Equity (US$ Millions)$28,083
Return On Equity (%)26.92%
Long Term Debt (US$ Millions)$29,306
Debt To Equity Ratio (%)1.04%
Market Capitalization (US$ Millions)$122,397
Total Assets (US$ Millions)$71,576
Current Assets (US$ Millions)$38,518
Inventories (US$ Millions)$2,435
Current Liabilities (US$ Millions)$8,667
Cost of Goods Sold (US$ Millions)$4,227
Asset Turnover0.3
Inventory Turnover1.66